| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 07/02/2008 | CN100398541C Pyrimidinone derivatives and 3-keto ester |
| 07/02/2008 | CN100398535C Piperidine derivatives and their use as modulators of chemokine receptor activity especially CCR5 |
| 07/02/2008 | CN100398153C Combined pharmaceutical application of antiangiogenic drugs and photosensitizers |
| 07/02/2008 | CN100398140C 'Yanxieting' oral liquid |
| 07/02/2008 | CN100398120C Full Chinese medicine oral liquid for improving eyesight |
| 07/01/2008 | US7393925 structural modification alters the biological persistence, preferably the biological half-life |
| 07/01/2008 | US7393840 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base |
| 07/01/2008 | US7393535 Adjuvants for use in vaccines |
| 06/26/2008 | WO2008075365A1 Compositions and methods for treatment of age related degeneration of the retina |
| 06/26/2008 | WO2008075152A1 1- [4- (sulfonyl) -phenyl] -5- (benzyl) -ih-i, 2, 4-triazol derivatives as inhibitors of carbonic anhydrase for treating glaucoma or ocular hypertension |
| 06/26/2008 | WO2008075149A2 Ophthalmic compositions of parasympathetic stimulants and anti-inflammatories for use in the treatment of presbyopia |
| 06/26/2008 | WO2008074227A1 Synthetic ion channels |
| 06/26/2008 | WO2008048121A3 Macrocyclic cysteine protease inhibitors and compositions thereof |
| 06/26/2008 | WO2008046228A8 Compounds for stimulating p-glycoprotein function and uses thereof |
| 06/26/2008 | WO2008006051A3 Bicyclic heteroaryl inhibitors of pde4 |
| 06/26/2008 | WO2008006050A3 Bicyclic heteroaryl inhibitors of pde4 |
| 06/26/2008 | WO2007104541A3 Compositions and methods using serine protease inhibiting peptides for treating ophthalmic disorders |
| 06/26/2008 | WO2007101005A3 Compositions and methods for effecting controlled posterior vitreous detachment |
| 06/26/2008 | US20080153909 Eye drops to treat dry eyes; omega-3 fatty acid is alpha linolenic acid; omega-6 fatty acid is gammalinolenic acid; free of linoleic acid and arachidonic acid; surfactant, saline solution; adenexal inflammation |
| 06/26/2008 | US20080153908 Method of Treating Mucin Deficiency with an Active Pharmaceutical and Related Composition |
| 06/26/2008 | US20080153903 Including bisindolylmaleimide I - IV, calphostin C, chelerythrine chloride, ellagic acid, hypericin, K-252a, K-252b, K-252c, melittin, NGIC-I, phloretin, staurosporine, polymyxin B sulfate, protein kinase C inhibitor peptide 19-31 or 19-36, Ro-31-8220, Ro-32-0432, rottlerin, safingol, and sangivamycin |
| 06/26/2008 | US20080153845 Administering N-(4-tert-butylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropryazine-1(2H)-carboxamide (BCTC) to inhibit unpleasant bitter, sour, hot/peppery, irritating, pungent, and astringent tastes; foods, drugs |
| 06/26/2008 | US20080153844 3-(Benzimidazol-2-yl)pyrazole derivatives; inhibitors of ATP and protein kinase interactions; diabetes, rheumatoid arthritis, Crohn's disease, septic shock, cachexia, pancreatitis, Alzheimer's disease, Parkinson's disease; antimetastasis, anticarcinogenic, antitumor, antidepressant, antiallergen agents |
| 06/26/2008 | US20080153835 Therapeutic agents useful for treating pain |
| 06/26/2008 | US20080153819 Methods for treating macular edema and pathologic ocular angiogenesis using a neuroprotective agent and a receptor tyrosine kinase inhibitor |
| 06/26/2008 | US20080153818 Methods for preventing inflammation during surgery |
| 06/26/2008 | US20080153815 Pinane-substituted pyrimidinediamine derivatives useful as axl inhibitors |
| 06/26/2008 | US20080153813 for using 6-aminoimidazo[1,2-b]pyridazine analogs are disclosed herein to treat rho kinase-mediated diseases or rho kinase-mediated conditions, including controlling intraocular pressure and treating glaucoma, are disclosed. Ophthalmic pharmaceutical compositions useful in the treatment of eye diseases |
| 06/26/2008 | US20080153791 Administering (2S,4aS,6aS,6bR,8aR,10S,12aS,12bR,;14bR)-10-(2-Carboxy-phenoxy)-2,4a,6a,;6b,9,9,12a-heptamethyl-13-oxo-1,2,;3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,;12a,12b,13,14b-icosahydro-picene-2-;carboxylic acid methyl ester; metabolic diseases, cancer, cell proliferation, glaucoma, |
| 06/26/2008 | US20080153776 Administering to an eye an aqueous solution of alginate having a minimum of about 50% mannuronate residues based upon the total number of saccharide monomeric units; no active pharmaceutical agent |
| 06/26/2008 | US20080153744 Novel cyclosporin alkynes and their utility as pharmaceutical agents |
| 06/26/2008 | US20080153742 Fas peptide mimetics and uses thereof |
| 06/26/2008 | US20080152710 Co-beadlet of dha and rosemary and methods of use |
| 06/26/2008 | US20080152694 Devices, Systems and Methods for Ophthalmic Drug Delivery |
| 06/26/2008 | US20080152669 Administering alginate; phosphate buffer, borate buffer, MOPS buffer, citrate buffer, an aminoalcohol buffer; ophthalmology |
| 06/26/2008 | US20080152659 Using presence of deletion in complement Factor H-related 4 gene as evaluative tool in predicting aneurysm and vision defects |
| 06/26/2008 | US20080152654 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ANGIOGENESIS |
| 06/26/2008 | US20080152629 Progenitor cell culture for use in partial and/or full restoration of hematopoietic function in patients who have undergone ablative therapy |
| 06/26/2008 | CA2672985A1 Ophthalmic compositions of parasympathetic stimulants and anti-inflammatories for use in the treatment of presbyopia |
| 06/25/2008 | EP1935874A1 S1p3 receptor antagonist |
| 06/25/2008 | EP1935427A2 Methods for treating rheumatoid diseases using a soluble CTLA4 mutant molecule |
| 06/25/2008 | EP1935420A1 2-Adamantyl-butyramide derivatives as selective 11beta-HSD1 inhibitors |
| 06/25/2008 | EP1933869A2 Use of il-23 and il-17 antagonists to treat autoimmune ocular inflammatory disease |
| 06/25/2008 | EP1933849A2 Use of at least one avermectin or milbemycin in the treatment of ophthalmic pathologies |
| 06/25/2008 | EP1418931B1 New angiogenesis inhibitors based on soluble cd44 receptor hyaluronic acid binding domain |
| 06/25/2008 | EP1351683B1 Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser |
| 06/25/2008 | EP0805859B2 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. |
| 06/25/2008 | CN101204579A Application of regrouped human minute plasminogen on process for preparing the medicine curing eye disorders |
| 06/25/2008 | CN101204451A Peroral Chinese traditional medicine prescription for glaucoma |
| 06/25/2008 | CN101204442A Health product of Chinese traditional medicine for glaucoma |
| 06/25/2008 | CN101204397A 一种稳定的复方滴眼液 A stable compound eye drops |
| 06/25/2008 | CN100396679C Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 06/25/2008 | CN100396668C Non-imidazole aryloxypiperidines |
| 06/25/2008 | CN100396334C Process to improve stability of pharmaceutical compsn |
| 06/24/2008 | US7392233 Image searching system, image searching method, and a recording medium storing an image searching program |
| 06/24/2008 | US7390924 Terphenyl derivatives, preparation thereof, compositions containing same |
| 06/24/2008 | US7390906 Forming ketone intermediates to terfenadine carboxylic acid metabolite; by use of pure regioisomer of 4-(Cyclopropyl-oxo-methyl)-alpha,alpha-dimethylphenylacetic acid |
| 06/24/2008 | US7390905 Tachykinin receptor antagonists for use treating e.g. emesis, depression, urinary disorder |
| 06/24/2008 | US7390821 Administering nicotinic acetylcholine receptor antagonist; ocular diseases; monoclonal antibodies |
| 06/24/2008 | US7390797 Fused indazole compounds |
| 06/24/2008 | US7390633 Methods for preparing low molecular weight heparin with modified heparinase III |
| 06/24/2008 | US7390484 Self-contained adipose derived stem cell processing unit |
| 06/24/2008 | US7390482 Drug for auditory dysfunction |
| 06/19/2008 | WO2008072726A1 1-phenyl 1-thio-d-glucitol derivative |
| 06/19/2008 | WO2008071803A1 Nutritional supplement composition for treatment of ocular diseases |
| 06/19/2008 | WO2008071775A1 Nutritional supplement composition for treatment of ocular diseases |
| 06/19/2008 | WO2008071528A1 Use of l-carnitine or of alkanoyl l-carnitines for the preparation of a physiological supplement or medicament for ophthalmic use in the form of eye drops |
| 06/19/2008 | WO2008071524A1 Use of l-carnitine for the preparation of a medicament in the form of eye-drops for treating corneal diseases |
| 06/19/2008 | WO2008071421A1 Nitrate esters of carbonic anhydrase inhibitors |
| 06/19/2008 | WO2008049043A3 Ophthalmic compositions comprising diglycine |
| 06/19/2008 | WO2008007244A3 Composition for improving eye health |
| 06/19/2008 | WO2008002582A8 Ultraviolet absorbing ophthalmic compositions |
| 06/19/2008 | US20080146821 Internal 1,15-Lactones Of Fluprostenol And Related Prostaglandin F2a Analogs And Their Use In The Treatment Of Glaucoma And Intraocular Hypertension |
| 06/19/2008 | US20080146679 Contacting the eye of a human in need with an effective amount of an electrokinetically altered oxygenated aqueous fluid ( saline solution, contact lens solution, storage, wetting or cleaning solultions) containing specific amount of oxygen; treats bacterial infection, dry eyes, allergical irritation |
| 06/19/2008 | US20080146635 Selective to alpha2B and/or alpha2C adrenergic receptors, minimal cardivascular and/or sedatory activity; treating pain, visceral pain, neuropathic pain, corneal pain, glaucoma, elevated intraocular pressure, ischemic neuropathies, neurodegenerative diseases, diarrhea, nasal congestion |
| 06/19/2008 | US20080146589 Chromenone derivatives |
| 06/19/2008 | US20080146560 1-[4-(4-amino-5-oxo-5H-pyrido[2,3-d]pyrimidin-8-yl)phenyl]-3-(5-tert-butylisoxazol-3-yl)urea; treatment of tyrosine kinase-induced diseases and conditions, such as angiogenesis, cancer, tumour formation, growth and propagation, arteriosclerosis, ocular diseases, such as age-induced macular degeneration |
| 06/19/2008 | US20080146553 Antibiotic compostions and methods for using same |
| 06/19/2008 | US20080146542 Hydrazinocarbonyl-thieno[2,3-C]pyrazoles, Process for Preparing Them, Compositions Containing Them and Use Thereof |
| 06/19/2008 | US20080146530 Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 06/19/2008 | US20080146501 identifying a subject at risk for developing AMD are disclosed. The methods include identifying specific protective or risk polymorphisms or genotypes from the subject's genetic material. Therapeutic compositions and methods are also provided for delaying the progression or onset of the development |
| 06/19/2008 | US20080146497 therapeutic methods, compositions, and medicaments related to cyclosporine. |
| 06/19/2008 | US20080145482 Black Soybean Hull Extract, Method For Obtaining, and Use Thereof |
| 06/19/2008 | US20080145459 Administering camphor, eucalyptus oil, and menthol to a nasal area |
| 06/19/2008 | US20080145430 With a surface stabilizer adsorbed on the surface; non-irritating and sufficiently bioavailable |
| 06/19/2008 | US20080145407 Biocompatible intraocular implants include a steroid and a polymer associated with each other to facilitate release of the steroid into an eye for a period of time greater than about two months. The steroid mmatrix of a two biodegradable polymer matrix |
| 06/19/2008 | US20080145406 Devices and methods for ophthalmic drug delivery |
| 06/19/2008 | US20080145359 Imaging, diagnosis and treatment of disease |
| 06/19/2008 | DE102006058209A1 New triterpene type compounds comprising a pentacyclic basic unit of nor-oleanane- or nor-ursane-type, are 11-beta-hydroxysteroid dehydrogenase inhibitors, useful e.g. to treat and prevent diabetes, depression and glaucoma |
| 06/19/2008 | DE102006058207A1 New triterpene type compounds comprising a pentacyclic basic structure of nor-oleanan- or non-ursan -types are 11-beta-hydroxysteroid dehydrogenase inhibitors, useful e.g. to treat and prevent the diabetes, depression and glaucoma |
| 06/19/2008 | CA2672176A1 1-phenyl 1-thio-d-glucitol derivative |
| 06/19/2008 | CA2672041A1 Nutritional supplement composition for treatment of ocular diseases |
| 06/19/2008 | CA2672013A1 Nutritional supplement composition for treatment of ocular diseases |
| 06/19/2008 | CA2667069A1 Use of l-carnitine for the preparation of a medicament in the form of eye-drops for treating corneal diseases |
| 06/18/2008 | EP1932841A1 Sulfonamide compound |
| 06/18/2008 | EP1932534A1 Method of inhibiting angiogenesis by using ephrin b2 |
| 06/18/2008 | EP1932521A1 Nutritional supplement composition for treatment of ocular diseases |
| 06/18/2008 | EP1932520A1 Nutritional supplement composition for treatment of ocular diseases |
| 06/18/2008 | EP1931388A2 Methods for treatment and prevention of otitis media using nonionic surfactants to facilitate transmembrane drug delivery into the middle ear |
| 06/18/2008 | EP1513803B1 Ligands that are inhibitors of the rar receptors |